sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 1345.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 22-Jun-2017
Nature Ecology & Evolution
Critical gaps in our knowledge of where infectious diseases occur
Today Scientists have called for action. The scientific journal Nature Ecology & Evolution have published a joint statement from scientists at Center for Macroecology, Evolution and Climate, University of Copenhagen and North Carolina State University. The scientists call attention to a serious lack of data on the worldwide distribution of disease-causing organisms. Without this knowledge, predicting where and when the next disease outbreak will emerge is hardly possible. Macroecologists hold the expertise to create the needed data network and close the knowledge gaps.

Contact: Anna-Sofie Stensgaard
asstensgaard@snm.ku.dk
45-26-29-76-50
Faculty of Science - University of Copenhagen

Public Release: 22-Jun-2017
PLOS Neglected Tropical Diseases
First Chikungunya-infected Aedes aegypti mosquitos found in Brazil
While more than 13,000 cases of Chikungunya viral disease were reported in Brazil in 2015, scientists had never before detected the virus in a captured mosquito in this country. Now, researchers reporting in PLOS Neglected Tropical Diseases have identified a mosquito -- caught in the Brazilian city of Aracaju -- that's naturally infected with the East-Central-South-African (ECSA) genotype of Chikungunya.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 21-Jun-2017
Lancet Global Health
CPAP improves respiratory and survival rates in children in Ghana
A new study found that applying continuous positive airway pressure (CPAP), a form of non-invasive ventilation, decreased mortality in children with respiratory distress. Findings from the trial in Ghana indicated that the procedure especially benefited children less than one year of age, confirmed that no serious adverse events were associated with the treatment, and is a step forward in treating children with respiratory distress in resource-limited settings.
General Electric Foundation, Columbia University sidHARTe Program

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 21-Jun-2017
Environmental Health
Common water treatments could damage DNA
Scientists are warning that a water treatment widely used in developing countries could be damaging the DNA of those drinking it. Despite poor evidence of their effectiveness as a water disinfectant, colloidal silver and silver nanoparticles are increasingly being promoted for treating potentially contaminated drinking water in low income countries. A study led by the University of East Anglia has concluded that there is a risk these treatments could in fact cause genotoxicity.

Contact: UEA Communications Office
press@uea.ac.uk
44-016-035-93496
University of East Anglia

Public Release: 21-Jun-2017
Clinical Infectious Diseases
Biological fingerprint of tuberculosis meningitis discovered in children
Children with tuberculosis meningitis have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments.

Contact: Greta Keenan
press@crick.ac.uk
020-379-65252
The Francis Crick Institute

Public Release: 21-Jun-2017
EHRA EUROPACE - CARDIOSTIM 2017
Stroke history higher in asymptomatic versus symptomatic atrial fibrillation patients
Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with symptoms, according to results from the GLORIA-AF Registry presented today at EHRA EUROPACE - CARDIOSTIM 2017. The findings highlight the need for screening to identify atrial fibrillation patients with no symptoms so that stroke prevention treatment can be given.
The study was sponsored by Boehringer Ingelheim.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 21-Jun-2017
EHRA EUROPACE - CARDIOSTIM 2017
Breast implants may impede ECG and lead to false heart attack diagnosis
Breast implants may impede an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research presented today at EHRA EUROPACE -- CARDIOSTIM 2017.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 20-Jun-2017
UW-led scientists 'closing the gap' on malaria in India
The National Institutes of Health has renewed a major grant that funds a University of Washington-led research center to understand malaria in India.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases

Contact: James Urton
jurton@uw.edu
206-543-2580
University of Washington

Public Release: 20-Jun-2017
EHRA EUROPACE - CARDIOSTIM 2017
Pacemakers and other cardiac devices can help solve forensic cases
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented today at EHRA EUROPACE - CARDIOSTIM 2017. Devices revealed the time and cause of death in some cases where autopsy failed to do so.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 20-Jun-2017
PLOS Medicine
Minimally invasive autopsy can identify causes of Mozambique newborn and childhood deaths
Minimally invasive autopsy can identify cause of death in pediatric, perinatal and neonatal deaths in Mozambique with significant precision and accuracy compared with complete diagnostic autopsy, according to two studies published by Clara Menéndez, Quique Bassat and colleagues from ISGlobal, Barcelona, Spain, in PLOS Medicine.

Contact: Clara Menéndez
clara.menendez@isglobal.org
PLOS

Public Release: 19-Jun-2017
Organic & Biomolecular Chemistry
CCNY researchers produce molecules with potential against HIV
As the HIV/AIDS epidemic approaches its fourth decade, each year brings promising news of pioneering research to alleviate the scourge. Add City College of New York scientists to the list with a rapid method to access new molecules that could inhibit the virus that causes AIDS.

Contact: Jay Mwamba
jmwamba@ccny.cuny.edu
212-650-7580
City College of New York

Public Release: 19-Jun-2017
PLOS Neglected Tropical Diseases
Mutant mosquitos make insecticide-resistance monitoring key to controlling Zika
One of the most common insecticides used in the battle against the Aedes aegypti mosquito has no measurable impact when applied in communities where the mosquito has built up resistance to it, a study led by Emory University finds.
Emory Global Health Institute and Marcus Foundation, Centers for Disease Control and Prevention, Mexico's CONACYT, National Health and Medical Research Council Senior Research Fellowship

Contact: Carol Clark
carol.clark@emory.edu
404-727-0501
Emory Health Sciences

Public Release: 19-Jun-2017
CU Anschutz and Baylor researchers to study Zika virus impact on children
Researchers at the University of Colorado Anschutz Medical Campus and the Baylor College of Medicine will join with Guatemalan investigators in a major study examining the clinical outcomes of children infected with the Zika virus after being born, focusing on long-term brain development.
National Institutes of Health

Contact: David Kelly
david.kelly@ucdenver.edu
303-503-7990
University of Colorado Anschutz Medical Campus

Public Release: 19-Jun-2017
EHRA EUROPACE - CARDIOSTIM 2017
Smartphone app directs first responders to cardiac arrest 3 minutes before ambulance
A novel smartphone application has been developed that can direct first responders to cardiac arrest victims more than three minutes before the emergency services arrive. Each minute increases the chance of survival by 10 percent.
UKSH Förderstiftung, University Clinic of Lübeck, EHRA Funding

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 19-Jun-2017
Clinical trial for a better treatment for mycetoma starts in Sudan
The first-ever double-blind, randomized clinical trial for an effective treatment for the severely neglected disease mycetoma has enrolled its first patient at the Mycetoma Research Centre (MRC) in Khartoum, Sudan.

Contact: Linet Otieno
latieno@dndi.org
254-733-624-206
Drugs for Neglected Diseases Initiative

Public Release: 19-Jun-2017
Nature Microbiology
How to stop the nasty lurking toxoplasmosis parasite? Target its 'stomach,' study suggests
One in three people has a potentially nasty parasite hiding inside their body -- tucked away in tiny cysts that the immune system can't eliminate and antibiotics can't touch. But new research reveals clues about how to stop it: Interfere with its digestion during this stubborn dormant phase. If the discovery leads to new treatments, it could help prevent a parasitic disease called toxoplasmosis that sickens people worldwide.
National Institutes of Health, American Heart Association

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
Michigan Medicine - University of Michigan

Public Release: 19-Jun-2017
Nature Microbiology
Scientists step closer to drug treatment for hepatitis B
A major new insight into how hepatitis B virus works could pave the way for new drug treatments for the infection which is the major cause of liver cancer worldwide.

Contact: Samantha Martin
s.martin@york.ac.uk
44-019-043-22029
University of York

Public Release: 19-Jun-2017
Canadian Medical Association Journal
Ebola vaccine developed in Canada shows promising results
A phase 1 randomized controlled trial has found an Ebola virus disease vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants six months after immunization. The study, led by Canadian researchers, is published in Canadian Medical Association Journal.

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
800-267-9703
Canadian Medical Association Journal

Public Release: 18-Jun-2017
EHRA EUROPACE - CARDIOSTIM 2017
Tenth year of data on cardiac arrhythmia treatment launched at European congress
The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017.
BIOTRONIK SE & Co. KG

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 15-Jun-2017
European Heart Journal - Cardiovascular Pharmacotherapy
Sex-specific cardiovascular drug dosages needed to reduce adverse reactions in women
Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology published today in the June issue of European Heart Journal - Cardiovascular Pharmacotherapy.
Spanish National Network on Cardiovascular Diseases

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 15-Jun-2017
PLOS Pathogens
Scientists reveal mechanism behind mosquito-borne-disease 'blocker' used to fight viruses
A new study from Indiana University may explain how a bacterium called Wolbachia prevents mosquitoes from transmitting deadly diseases such as dengue fever, West Nile virus and Zika.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases

Contact: Kevin D. Fryling
kfryling@iu.edu
812-856-2988
Indiana University

Public Release: 15-Jun-2017
PLOS Neglected Tropical Diseases
8 in 10 Indonesian children has been infected with dengue
Indonesia has one of the highest burdens of dengue fever, a mosquito-borne virus, in the world, and children account for many cases. Well over half of all children in urban areas are infected with dengue by the age of 5, and more than 80 percent have been infected with the virus at least once by age 10, researchers now report in PLOS Neglected Tropical Diseases.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 14-Jun-2017
Environmental Research Letters
Temperature changes make it easier for malaria to climb the Ethiopian highlands
The highlands of Ethiopia are home to the majority of the country's population, the cooler climate serving as a natural buffer against malaria transmission. New data now show that increasing temperatures over the past 35 years are eroding this buffer, allowing conditions more favorable for malaria to begin climbing into highland areas.

Contact: Simon Davies
simon.davies@iop.org
44-011-793-01110
IOP Publishing

Public Release: 14-Jun-2017
Cell Host and Microbe
Anti-malaria drugs: Potential new target identified
A newly described protein could be an effective target for combatting drug-resistant malaria parasites. The protein regulates a number of genes involved with a critical part of the parasite's complex life cycle -- its invasion of a person's red blood cells. Now that the researchers know the protein's role in this invasion process, they have a completely new angle for developing new antimalarial drugs for targeting the malaria parasite.
National Institutes of Health, Arnold and Mabel Beckman Foundation, Princeton Center for Quantitative Biology

Contact: Barbara K. Kennedy
bkk1@psu.edu
814-863-4682
Penn State

Public Release: 13-Jun-2017
Science
Argonne X-rays used to help identify a key Lassa virus structure
Research done at Argonne National Laboratory's Advanced Photon Source was vital to the process of identifying the structure, which provides a guide for designing a Lassa virus vaccine. Lassa virus is endemic to Africa and kills thousands of people a year; it is particularly deadly for pregnant women.

Contact: Karen Mellen
kmellen@anl.gov
630-252-5325
DOE/Argonne National Laboratory

Showing releases 101-125 out of 1345.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>